Table of Contents
The Brown University Geriatric Psychopharmacology Update · 2005
DOI: 10.1002/gpu.20000906 ↗At a glance
Journal article in The Brown University Geriatric Psychopharmacology Update, 2005.
Abstract (original language)
Is Shift from Lithium to Valproate Justified? Osteoporosis Drug, Raloxifene, May Lower Risk for Cognitive Impairment Movement Disorder – Asterixis – May Be Associated with Gabapentin Propranolol May Reduce Disruptive Behavior in Alzheimer's Patients Atorvastatin Shows Positive Effects for Treatment of Mild to Moderate AD Possible Neuroprotective Effect of Donepezil in AD Effects of Donepezil in Older Healthy Adults Studied “Do the Right Dose” – Campaign to Reduce Substance Abuse in Older Adults ECT Response Not Always Related to Seizure Duration FDA Warning on Zoloft Advertising Pfizer Recall of Neurontin Lot #15224V Ropinirole Approved for Restless Legs Syndrome
Cite
APA
(2005). Table of Contents. The Brown University Geriatric Psychopharmacology Update. https://doi.org/10.1002/gpu.20000906
Vancouver
Table of Contents. The Brown University Geriatric Psychopharmacology Update. 2005. doi:10.1002/gpu.20000906
BibTeX
@article{euvimed2005,
title = {Table of Contents},
journal = {The Brown University Geriatric Psychopharmacology Update},
year = {2005},
doi = {10.1002/gpu.20000906}
}
EUVIMED